Author

Y.-S. Hu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Y. Cheng· 2 shared A. L. Berr· 1 shared A. V. Misharin· 1 shared B. M. Coates· 1 shared C. Koch· 1 shared C. M. Koch· 1 shared D. R. Winter· 1 shared G. dos Santos· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Y. Cheng

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Influenza-induced activation of recruited alveolar macrophages during the early inflammatory phase drives lung injury and lethality

C. M. Koch, K. Anekalla, Y.-S. Hu, J. M. Davis, M. Ciesielski, G. Gadhvi, S.-Y. Chen, M. Turner, Y. Cheng, B. M. Coates, H. Abdala-Valencia, P. A. Reyfman, A. V. Misharin, G. S. Budinger, D. R. Winter, K. M. Ridge

This study identifies vimentin's role in driving pro-inflammatory responses in alveolar macrophages during influenza infection, linking it to lung injury and mortality.

bioRxiv · Jun 8, 2020 · PreprintImmunology

Vimentin is Required for Tumor Progression and Metastasis in a Mouse Model of Non-Small Cell Lung Cancer

A. L. Berr, K. Wiese, G. dos Santos, J. Davis, C. Koch, K. R. Anekalla, M. Kidd, Y. Cheng, Y.-S. Hu, K. Ridge

This study shows that vimentin is essential for metastasis in a mouse model of non-small cell lung cancer, as its loss impairs epithelial-to-mesenchymal transition and oxidative stress response.

bioRxiv · Jun 4, 2020Cancer Biology